Regeneron Hires Firm to Market Former Avon R&D Facility in Suffern for Sale or Lease
Regeneron Pharmaceuticals abandoned plans last November to spend $139 million to renovate the former Avon Products facility it had acquired in December 2023 for $38,875,000 from Avon Capital Corp.
From left, Gail Fattizzi with Cynthia and Joe Lippollis
From left, Royston Pinnock and Bita Taghvai
From left, HGAR CEO Richard Haggerty, Rich Herska, Leah Caro and Ron Garafalo
The event was held at the TVB by: Pax Romana in White Plains.